Benin vs Mali: Tuberculosis patients living with HIV receiving antiretroviral therapy
Benin
477 patients
in 2021
Mali
518 patients
in 2021
Benin rank
51st
Mali rank
48th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Benin
- Mali
How they compare
Mali currently reports 518 patients against 477 patients in Benin, a difference of 41 patients.
That makes Mali's figure about 1.1 times Benin's.
The two have swapped places 1 time across 13 shared years of data; in 2008 it was Benin ahead.
Benin ranks 51st and Mali ranks 48th of 183 countries.
Across the 3 decades both report, Benin averaged higher in 2 and Mali in 1.
Head to head by decade
| Decade | Benin | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 268.5 patients | 39 patients | 229.5 patients | Benin |
| 2010s | 515.44 patients | 397.11 patients | 118.33 patients | Benin |
| 2020s | 500.5 patients | 509.5 patients | 9 patients | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Benin or Mali?
- Mali, at 518 patients against 477 patients in Benin as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Benin and Mali?
- 41 patients, with Mali ahead.
- How many years of comparable data are there for Benin and Mali?
- 13 years are reported by both, from 2008 to 2021.
- How do Benin and Mali rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Benin ranks 51st and Mali ranks 48th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.